Dr. Stacey Clardy talks with Dr. Chloe Hill about increasing out-of-pocket costs for privately-insured patients to obtain neurologic diagnostic services.
The Neurology HSR group is frequently interviewed about topics involving healthcare policy, drug costs, healthcare efficiencies, and other important health services research related topics. CNN and the LA times are just 2 examples of high profile media outlets that have highlighted our work. We are frequently interviewed by the American Academy of Neurology, the largest organization of neurologists in the United States.
Special Report: Patients’ out of pocket costs in neurology
"Out-of-pocket costs have risen to the point where neurologists should be able to consider the potential financial burden for the patient when prescribing medication, but they do not have this information available to them,"
Patients are paying up to 20 times more for neurological drugs since 2004, study finds
Out-of-pocket costs for Americans with neurologic conditions have risen so rapidly over 12 years, a new study says, that doctors need better access to drug price information "to minimize patient financial burden."
Soaring insurance deductibles and high drug prices hit sick Americans with a ‘double whammy’
As drug prices have skyrocketed and deductibles in job-based coverage have more than tripled in the last 12 years, soaring to an annual average of $1,350, these sick Americans now routinely pay thousands of dollars every year to get care they need. That has made being sick in the U.S. dramatically more expensive.
Unintended effects of no-fault changes; worker shortage in Traverse City; Faygo cocktails
These short audio segments highlight the rising out-of-pocket costs for neurologic medications. While these costs were small in 2001, they have become increasingly important especially for those in high deductible healthcare plans.
Medicare shouldn’t pay more for drugs when others pay less
Hillary Clinton and Donald Trump don’t see eye-to-eye on much. But they do agree that drug costs are spiraling out of control at the public’s expense.
If Medicare had been able to negotiate drug prices and pay the same amount that the VA pays for these same medications, we would have saved $1.8 billion. That estimate is likely on the low end, as Medicare Part D covers many more individuals than veterans, giving Medicare even greater buying power.
